|
|
|
| Professor Cao Zhiqun’s experience in treating refractory gastroesophageal reflux disease#br# |
| GAO Hui1 ZHAN Junyi2 QU Yi3 WANG Dongyuan4 CAO Zhiqun5 |
1.School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China;
2.the First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China;
3.Shanghan Teaching and Research Section, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250355, China;
4.Department of Emergency, Shandong Electric Power Central Hospital, Shandong Province, Jinan 250001, China;
5.Department of Digestive Endoscopy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China |
|
|
|
Abstract This paper summarizes the clinical experience of Professor Cao Zhiqun in the treatment of refractory gastroesophageal reflux disease, and elaborates on two aspects of etiology and pathogenesis, and specific treatment experience. Professor Cao Zhiqun has concluded that the occurrence of refractory gastroesophageal reflux disease is closely related to stagnation fire in his long-term clinical practice. The basis of refractory gastroesophageal reflux disease is qi depression which causes the stomach to lose its balance. It is considered that the treatment should follow the principle of release of fire stagnation, to deal with the cause of stagnation fire, opening the stagnant blockage is the first step. In response to the results of the heat of stagnation, the method of clearing heat is added to the method of dispersing and clearing heat, while taking care of nourishing yin fluid. For the stasis, he focuses on regulating spleen and stomach qi. Clinical treatment is specifically based on three aspects, opening and clearing up stagnation, clearing the heat of stagnation, and nourishing yin fluid, making spleen and stomach get the balance.
|
|
|
|
|
|
[1] Stefanidis G，Viazis N，Kotsikoros N，et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy [J]. Dis Esophagus，2017，30（3）：1-8.
[2] 梁笑楠，战蓉蓉，张晓岚.《2020年中国胃食管反流病专家共识》解读[J].河北医科大学学报，2021，42（8）：869-871，925.
[3] Zerbib F，Bredenoord AJ，Fass R，et al. ESNM/ANMS consensus paper：diagnosis and management of refractory gastroesophageal reflux disease [J]. Neurogastroenterol Motil，2021，33（4）：e14075.
[4] Fock KM，Talley NJ，Fass R，et al.亚太地区胃食管反流病的处理共识：更新版[J].胃肠病学，2008，13（7）：421-436.
[5] 中华医学会消化病学分会.2014年中国胃食管反流病专家共识意见[J].胃肠病学，2015，20（3）：155-168.
[6] Iwakiri K，Kinoshita Y，Habu Y，et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015 [J]. J Gastroenterol，2016，51（8）：751-767.
[7] Fock KM，Talley N，Goh KL，et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease：an update focusing on refractory reflux disease and Barrett’s oesophagus [J]. Gut，2016，65（9）：1402-1415．
[8] 谢胜，李建锋，李娟，等.难治性胃食管反流病临床指南的系统评价[J].中国全科医学，2019，22（8）：901-908.
[9] 李业欢.黛力新联合伊托必利治疗难治性胃食管反流病的临床研究[J].中国医药科学，2020，10（18）：75-78.
[10] 孙一奎.赤水玄珠[M].北京：中国医药科技出版社，2011：237.
[11] 殷鸣，金钊，张琦.金元医家郁火理论汇通[J].中国中医基础医学杂志，2020，26（11）：1598-1600，1742.
[12] 黄玉燕，郑齐，汤尔群，等.运气“火郁发之”析微[J].环球中医药，2017，10（11）：1338-1341.
[13] 张仲景.伤寒论[M].北京：人民卫生出版社，2005：39.
[14] 张从正.儒门事亲[M].天津：天津科学技术出版社，1999：57.
[15] 张声生，朱生樑，王宏伟，等.胃食管反流病中医诊疗专家共识意见（2017）[J].中国中西医结合消化杂志，2017， 25（5）：321-326.
[16] 黄元御.玉楸药解[M].北京：中国医药科技出版社，2017：4.
[17] 唐容川.血证论[M].北京：中国医药科技出版社，2011：8.
[18] 田代华.黄帝内经素问[M].北京：人民卫生出版社，2005：20-188.
[19] 许慎.说文解字[M].北京：中华书局，2009：207.
[20] 李用梓.证治汇补[M].北京：人民卫生出版社，2006：270.
[21] 王静宇，谭东宇，康伟聪，等.国医大师李士懋先生“火郁发之”常用药对探析[J].时珍国医国药，2019，30（4）：988-989.
[22] 清?王孟英.温热经纬[M].北京：人民卫生出版社，2005：138.
[23] 李东垣.脾胃论[M].北京：人民卫生出版社，2005：33.
[24] 寇宗奭.本草衍义·本草衍句合集[M].太原：山西科学技术出版社，2012：74.
[25] 杨武韬.三七化学成分分离及药理作用研究探讨[J].航空航天医学杂志，2019，30（5）：586-587，592.
[26] 孔伟华，徐建波，崔琦，等.白及化学成分、药理作用和白及多糖提取工艺的研究进展[J].中医药信息，2021， 38（9）：69-78. |
|
|
|
